Catalent, Inc. (NYSE:CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that Matthew Walsh, Executive Vice President & Chief Financial Officer, will present at the 29^th Annual Piper Jaffray Healthcare Conference at 2:00 p.m. EST on Tuesday, November 28, 2017 in New York City.

A live webcast of the presentation will be accessible through the Company's website at http://investor.catalent.com and will be available for replay following the event.

About Catalent, Inc.

Catalent is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs over 10,000 people, including over 1,400 scientists, at more than 30 facilities across 5 continents and in fiscal 2017 generated more than $2 billion in annual revenue. Catalent is headquartered in Somerset, N.J. For more information visit www.catalent.com.

More products. Better treatments. Reliably supplied.™

View source version on businesswire.com: http://www.businesswire.com/news/home/20171114006638/en/